{"id":2867,"date":"2019-09-06T16:35:48","date_gmt":"2019-09-06T20:35:48","guid":{"rendered":"https:\/\/www.conferencecannabis.ca\/silicycle-obtient-sa-licence-de-recherche-de-sante-canada\/"},"modified":"2019-09-10T13:28:12","modified_gmt":"2019-09-10T17:28:12","slug":"silicycle-receives-its-health-canada-research-license","status":"publish","type":"post","link":"https:\/\/www.conferencecannabis.ca\/en\/silicycle-receives-its-health-canada-research-license\/","title":{"rendered":"SiliCycle receives its Health Canada Research license"},"content":{"rendered":"

Quebec, September 6, 2019<\/strong> – SiliCycle is moving forward in its research for processes to extract and purify the various cannabinoids contained in cannabis and hemp. The company aims to obtain pure, high-quality extracts that are free of pesticides and other undesirable molecules. It is with this in mind that the company is pleased to have taken another step towards this goal by obtaining from Health Canada a research license to continue its work. SiliCycle is now tackling the development of innovative extraction and purification processes for different biomasses of cannabis.<\/p>\n

“We’re seeing a trend for cannabinoid production, but even more so with the potential to offer these substances in pure form or standardized specifically for inclusion in other products. These applications will make natural mixtures consistent in order to have the desired amounts and proportions in a stable and predictable manner despite the variations of these molecules in plants. In this way, we will be able to provide the clientele with the expected effects, an essential condition for commercial success, “said SiliCycle President Hugo St-Laurent.<\/p>\n

It should be noted that pure cannabinoids are also sought after by the pharmaceutical industry, in particular CBD, given the absence of euphoric effects, as well as CBG and CBN. SiliCycle is counting on the forthcoming opening of its plant to implement efficient and environmentally friendly extraction and purification processes that will make it possible to develop a wide variety of hemp and cannabis-based biomass products. In January, the company created a new division, PurCann Pharma, to foresee and manage this project.<\/p>\n

The plant’s processing capacity will reach 15,000 kg per day which will enable SiliCycle to produce hundreds of kilograms of different types of extracts. The plant will also be equipped with finished product preparation units including capsules, tinctures, etc. to meet customer needs, thus the need for Health Canada’s approval and obtaining the required license.<\/p>\n

About SiliCycle Inc.<\/strong><\/p>\n

Founded in 1995, SiliCycle\u00ae Inc. is a worldwide leader in the development, the manufacturing and the commercialization of high value silica-based and specialty products for chromatography, analytical and organic chemistry. Our business extends to more than fifty countries and our customer portfolio includes companies in the pharmaceutical and biopharmaceutical industries, contract research and manufacturing organizations as well as university laboratories, hospital research centers, agriculture and food, environmental, petrochemicals, and industrial process companies. Our offer includes among others services:<\/p>\n